EDX Medical confirms date for 2025 Annual General Meeting

EDX Medical Group Plc (AQSE: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, has announced that its annual general meeting (AGM) will be held at the Marcus Beck Library, 3rd Floor, Royal School of Medicine, 1 Wimpole Street, Westminster, London, W1G 0AE on 29 September 2025 at 2:00 p.m.

The annual report and financial statements for the year ended 31 March 2025, Notice of AGM and Form of Proxy will be posted today, 1 September 2025, to eligible shareholders. Electronic copies will be shortly available on the Company’s website at: https://edxmedical.co.uk/documents/

Share on:

Written by: Amilia Stone

Find more news, interviews, share price & company profile here for:
EDX Medical Group plc

Latest Company News

EDX Medical Group Targets More Than £2 Million From New Employee Health Screening Service (video)

July 16, 2026

Chief Scientific Officer Sir Chris Evans explains how its on-site testing model, multi-biomarker panels and personalised reports could help employers identify health risks earlier while reducing disruption and absenteeism.

EDX Medical builds scale through Scottish Prostate Cancer Testing programme

July 15, 2026

EDX Medical is expanding its role in a 25,000-participant Scottish programme testing a more targeted approach to prostate cancer detection.

EDX Medical builds momentum around precision cancer testing

July 7, 2026

EDX Medical is advancing precision cancer diagnostics through large-scale prostate testing in Scotland, AIM market access and a wider commercial rollout of disease detection products.

EDX Medical backs large-scale prostate cancer testing in Scotland

June 10, 2026

EDX Medical is supporting a Scottish prostate cancer testing programme for 25,000 men, strengthening its position in early cancer detection and practical diagnostic services.

AIM admission marks new phase for EDX Medical’s diagnostic expansion

June 3, 2026

EDX Medical has joined AIM as it advances the commercial rollout of diagnostic tests targeting cancer and other major diseases, supported by growing clinical screening programmes.

EDX Medical targets AIM growth with ultra-accurate cancer diagnostics

May 20, 2026

EDX Medical Chief Scientific Officer Professor Chris Evans discusses the company’s AIM admission, prostate cancer testing programme in Scotland, and plans to commercialise a range of advanced diagnostic tests.

EDX Medical confirms date for 2025 Annual General Meeting

We’ll keep you in the loop!

Latest Company News

Search

Follow us on Social Media: